

Big Tech Sells Off.. And Viking Therapeutics Plunges On Weight Loss Pill Data 8/19/25
Aug 19, 2025
Big tech struggles with a sell-off as the Mag-7 stocks drag down the market. A deep dive into the semiconductor sector reveals NVIDIA's sharp decline impacting cryptocurrencies. Viking Therapeutics faces a major setback after poor data from a weight loss drug trial raises questions about its future. Insights into housing market challenges reflect changing consumer trends, while investment opportunities in the weight loss sector emerge amidst fierce competition. Innovative beverage trends are also reshaping the restaurant industry.
AI Snips
Chapters
Transcript
Episode notes
Tech Rotation Not Apocalypse
- The Magnificent Seven and AI-linked names led a broad tech sell-off that pulled the Nasdaq down sharply.
- Panelists said the move looked like rotation after an extraordinary multi-month run, not a structural collapse.
Rising Global Yields Pressure Tech
- Tim Seymour called the tech rally extremely durable but acknowledged short-term rotation into defensive sectors.
- He highlighted rising global long-term yields as a background reason for recent risk-off moves.
Valuations Drive Volatility
- Dan Nathan argued Palantir's valuation reflects a disconnect between hype and fundamentals, calling it a bubble.
- He warned high multiples leave no margin for error and can produce sharp sell-offs on minor disappointments.